Refinement of the pharmacophore of an agonist ligand of the secretin receptor using conformationally constrained cyclic hexapeptides

Maoqing Dong, Pooja Narang, Delia I. Pinon, Andrew J. Bordner, Laurence J Miller

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

There is a compelling need for the development of small molecule agonists acting at family B G protein-coupled receptors. A possible lead for the development of such drugs was reported when it was recognized that sequences endogenous to the amino terminus of the secretin receptor and certain other receptors in this family possess weak full agonist activity (Dong et al. Mol Pharmacol 2006;70:206-213). In the current report, we extended those observations by building the active dipeptide motif found in the secretin receptor (WD) into each position around a conformationally constrained d-amino acid-containing cyclic hexapeptide, and determining the biological activity of each peptide at the secretin receptor. Indeed, only two positions for WD around this constrained ring resulted in biological activity at the receptor, providing further insights into the structural specificity of this phenomenon. Molecular modeling supported the presence of a unique WD backbone conformation shared only by these active peptides, and provided a more constrained template for future receptor-active agonist drug development.

Original languageEnglish (US)
Pages (from-to)1094-1098
Number of pages5
JournalPeptides
Volume31
Issue number6
DOIs
StatePublished - Jun 2010

Fingerprint

Ligands
Bioactivity
Cyclic Amino Acids
Peptides
Molecular modeling
Dipeptides
G-Protein-Coupled Receptors
Pharmaceutical Preparations
Conformations
Amino Acids
Molecules
secretin receptor
Lead

Keywords

  • Cyclic peptide
  • G protein-coupled receptor
  • Hexapeptide
  • Molecular modeling
  • Receptor activation
  • Secretin receptor

ASJC Scopus subject areas

  • Biochemistry
  • Endocrinology
  • Physiology
  • Cellular and Molecular Neuroscience

Cite this

Refinement of the pharmacophore of an agonist ligand of the secretin receptor using conformationally constrained cyclic hexapeptides. / Dong, Maoqing; Narang, Pooja; Pinon, Delia I.; Bordner, Andrew J.; Miller, Laurence J.

In: Peptides, Vol. 31, No. 6, 06.2010, p. 1094-1098.

Research output: Contribution to journalArticle

Dong, Maoqing ; Narang, Pooja ; Pinon, Delia I. ; Bordner, Andrew J. ; Miller, Laurence J. / Refinement of the pharmacophore of an agonist ligand of the secretin receptor using conformationally constrained cyclic hexapeptides. In: Peptides. 2010 ; Vol. 31, No. 6. pp. 1094-1098.
@article{4d6372fa3e74434abf0410eff649a365,
title = "Refinement of the pharmacophore of an agonist ligand of the secretin receptor using conformationally constrained cyclic hexapeptides",
abstract = "There is a compelling need for the development of small molecule agonists acting at family B G protein-coupled receptors. A possible lead for the development of such drugs was reported when it was recognized that sequences endogenous to the amino terminus of the secretin receptor and certain other receptors in this family possess weak full agonist activity (Dong et al. Mol Pharmacol 2006;70:206-213). In the current report, we extended those observations by building the active dipeptide motif found in the secretin receptor (WD) into each position around a conformationally constrained d-amino acid-containing cyclic hexapeptide, and determining the biological activity of each peptide at the secretin receptor. Indeed, only two positions for WD around this constrained ring resulted in biological activity at the receptor, providing further insights into the structural specificity of this phenomenon. Molecular modeling supported the presence of a unique WD backbone conformation shared only by these active peptides, and provided a more constrained template for future receptor-active agonist drug development.",
keywords = "Cyclic peptide, G protein-coupled receptor, Hexapeptide, Molecular modeling, Receptor activation, Secretin receptor",
author = "Maoqing Dong and Pooja Narang and Pinon, {Delia I.} and Bordner, {Andrew J.} and Miller, {Laurence J}",
year = "2010",
month = "6",
doi = "10.1016/j.peptides.2010.02.024",
language = "English (US)",
volume = "31",
pages = "1094--1098",
journal = "Peptides",
issn = "0196-9781",
publisher = "Elsevier Inc.",
number = "6",

}

TY - JOUR

T1 - Refinement of the pharmacophore of an agonist ligand of the secretin receptor using conformationally constrained cyclic hexapeptides

AU - Dong, Maoqing

AU - Narang, Pooja

AU - Pinon, Delia I.

AU - Bordner, Andrew J.

AU - Miller, Laurence J

PY - 2010/6

Y1 - 2010/6

N2 - There is a compelling need for the development of small molecule agonists acting at family B G protein-coupled receptors. A possible lead for the development of such drugs was reported when it was recognized that sequences endogenous to the amino terminus of the secretin receptor and certain other receptors in this family possess weak full agonist activity (Dong et al. Mol Pharmacol 2006;70:206-213). In the current report, we extended those observations by building the active dipeptide motif found in the secretin receptor (WD) into each position around a conformationally constrained d-amino acid-containing cyclic hexapeptide, and determining the biological activity of each peptide at the secretin receptor. Indeed, only two positions for WD around this constrained ring resulted in biological activity at the receptor, providing further insights into the structural specificity of this phenomenon. Molecular modeling supported the presence of a unique WD backbone conformation shared only by these active peptides, and provided a more constrained template for future receptor-active agonist drug development.

AB - There is a compelling need for the development of small molecule agonists acting at family B G protein-coupled receptors. A possible lead for the development of such drugs was reported when it was recognized that sequences endogenous to the amino terminus of the secretin receptor and certain other receptors in this family possess weak full agonist activity (Dong et al. Mol Pharmacol 2006;70:206-213). In the current report, we extended those observations by building the active dipeptide motif found in the secretin receptor (WD) into each position around a conformationally constrained d-amino acid-containing cyclic hexapeptide, and determining the biological activity of each peptide at the secretin receptor. Indeed, only two positions for WD around this constrained ring resulted in biological activity at the receptor, providing further insights into the structural specificity of this phenomenon. Molecular modeling supported the presence of a unique WD backbone conformation shared only by these active peptides, and provided a more constrained template for future receptor-active agonist drug development.

KW - Cyclic peptide

KW - G protein-coupled receptor

KW - Hexapeptide

KW - Molecular modeling

KW - Receptor activation

KW - Secretin receptor

UR - http://www.scopus.com/inward/record.url?scp=77952101200&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77952101200&partnerID=8YFLogxK

U2 - 10.1016/j.peptides.2010.02.024

DO - 10.1016/j.peptides.2010.02.024

M3 - Article

VL - 31

SP - 1094

EP - 1098

JO - Peptides

JF - Peptides

SN - 0196-9781

IS - 6

ER -